THISX Holdings — T. Rowe Price Health Sciences Fund, Inc.
Data updated: 2026-08-27
THISX holds 279 securities. The top 10 make up 47.6% of net assets, led by Eli Lilly & (14.28%) and Johnson & Johnson (6.63%). Health Care (98.9%) and Funds & ETFs (0.7%) are the largest sectors, and 92.6% of the portfolio is in United States. Debt holdings: 7 positions, 0.1% of assets.
Holdings cover 100.16% of net asset value (99.90% of total assets; remainder is cash and receivables). As of June 30, 2026 · N-PORT.
THISX Portfolio Holdings
279 holdings of T. Rowe Price Health Sciences Fund, Inc. by percentage of net assets, from the fund's SEC N-PORT filing as of June 30, 2026. The 100 largest are listed below; the interactive table on this page lists all 279.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Eli Lilly & Co. | LLY | Health Care | 14.28% | $1.71B |
| Johnson & Johnson | JNJ | Health Care | 6.63% | $792.01M |
| Unitedhealth Group, Inc. | UNH | Health Care | 5.99% | $715.61M |
| Abbvie, Inc. | ABBV | Health Care | 5.10% | $609.30M |
| Merck & Co., Inc. | MRK | Health Care | 4.01% | $478.73M |
| Gilead Sciences, Inc. | GILD | Health Care | 2.82% | $336.99M |
| Thermo Fisher Scientific, Inc. | TMO | Health Care | 2.52% | $301.21M |
| Vertex Pharmaceuticals, Inc. | VRTX | Health Care | 2.28% | $272.28M |
| Bristol-Myers Squibb Co. | BMY | Health Care | 2.11% | $251.85M |
| Abbott Laboratories | ABT | Health Care | 1.89% | $225.34M |
| Intuitive Surgical, Inc. | ISRG | Health Care | 1.87% | $223.73M |
| Amgen, Inc. | AMGN | Health Care | 1.82% | $217.35M |
| Stryker Corp. | SYK | Health Care | 1.78% | $212.88M |
| Elevance Health, Inc. | ELV | Health Care | 1.53% | $182.63M |
| Natera, Inc. | NTRA | Health Care | 1.44% | $171.60M |
| Danaher Corp. | DHR | Health Care | 1.43% | $170.25M |
| Guardant Health, Inc. | GH | Health Care | 1.23% | $146.37M |
| Cardinal Health, Inc. | CAH | Health Care | 1.03% | $123.35M |
| Royalty Pharma PLC | RPRX | Health Care | 0.97% | $115.61M |
| Cvs Health Corp. | CVS | Health Care | 0.94% | $111.95M |
| Tenet Healthcare Corp. | THC | Health Care | 0.94% | $111.93M |
| Kymera Therapeutics, Inc. | KYMR | Health Care | 0.89% | $106.07M |
| Protagonist Therapeutics, Inc. | PTGX | Health Care | 0.85% | $101.56M |
| Moderna, Inc. | MRNA | Health Care | 0.83% | $98.94M |
| Brightspring Health Services, Inc. | BTSG | Health Care | 0.82% | $98.28M |
| Revolution Medicines, Inc. | RVMD | Health Care | 0.78% | $92.80M |
| Roivant Sciences Ltd. | ROIV | Health Care | 0.70% | $83.96M |
| Alnylam Pharmaceuticals, Inc. | ALNY | Health Care | 0.67% | $80.19M |
| Viatris, Inc. | VTRS | Health Care | 0.66% | $78.56M |
| Charles River Laboratories International, Inc. | CRL | Health Care | 0.62% | $73.99M |
| Argenx SE | ARGX | Health Care | 0.59% | $71.09M |
| Edwards Lifesciences Corp. | EW | Health Care | 0.59% | $70.59M |
| Centene Corp. | CNC | Health Care | 0.57% | $67.92M |
| Spyre Therapeutics, Inc. | SYRE | Health Care | 0.53% | $63.20M |
| Definium Therapeutics, Inc. | DFTX | Health Care | 0.51% | $60.56M |
| T. Rowe Price Government Reserve Fund | — | Funds & ETFs | 0.50% | $60.05M |
| Insmed, Inc. | INSM | Health Care | 0.49% | $58.46M |
| Twist Bioscience Corp. | TWST | Health Care | 0.48% | $57.10M |
| FOG PHARMACEUTICALS SERIES C restricted Common Stock lockup | — | Health Care | 0.47% | $56.05M |
| Chugai Pharmaceutical Co. Ltd. | — | Health Care | 0.45% | $54.12M |
| Astrazeneca PLC | AZN | Health Care | 0.44% | $52.95M |
| United Therapeutics Corp. | UTHR | Health Care | 0.44% | $52.37M |
| Krystal Biotech, Inc. | KRYS | Health Care | 0.43% | $51.61M |
| Boston Scientific Corp. | BSX | Health Care | 0.43% | $51.07M |
| Medtronic PLC | MDT | Health Care | 0.41% | $49.30M |
| Erasca, Inc. | ERAS | Health Care | 0.40% | $47.35M |
| Billiontoone, Inc. | BLLN | Health Care | 0.38% | $45.30M |
| Praxis Precision Medicines, Inc. | PRAX | Health Care | 0.37% | $44.63M |
| Medpace Holdings, Inc. | MEDP | Health Care | 0.37% | $44.56M |
| Monte Rosa Therapeutics, Inc. | GLUE | Health Care | 0.37% | $44.12M |
| Tango Therapeutics, Inc. | TNGX | Health Care | 0.37% | $43.80M |
| Oruka Therapeutics, Inc. | ORKA | Health Care | 0.36% | $42.93M |
| Ascendis Pharma A/s | ASND | Health Care | 0.36% | $42.64M |
| Beone Medicines Ltd. | BEIGF | Health Care | 0.35% | $42.33M |
| Humana, Inc. | HUM | Health Care | 0.35% | $42.22M |
| Dianthus Therapeutics, Inc. | DNTH | Health Care | 0.35% | $41.79M |
| Scholar Rock Holding Corp. | SRRK | Health Care | 0.34% | $40.60M |
| Kodiak Sciences, Inc. | KOD | Health Care | 0.33% | $39.49M |
| Axsome Therapeutics, Inc. | AXSM | Health Care | 0.31% | $37.01M |
| Summit Therapeutics, Inc. | SMMT | Health Care | 0.31% | $36.88M |
| Novo Nordisk A/s | NVO | Health Care | 0.30% | $36.06M |
| Regeneron Pharmaceuticals, Inc. | REGN | Health Care | 0.29% | $34.71M |
| Relay Therapeutics, Inc. | RLAY | Health Care | 0.29% | $34.44M |
| Ionis Pharmaceuticals, Inc. | IONS | Health Care | 0.29% | $34.41M |
| Cytokinetics, Inc. | CYTK | Health Care | 0.28% | $33.69M |
| Vera Therapeutics, Inc. | VERA | Health Care | 0.28% | $33.65M |
| Enliven Therapeutics, Inc. | ELVN | Health Care | 0.28% | $32.86M |
| Agilent Technologies, Inc. | A | Health Care | 0.27% | $32.52M |
| Mbx Biosciences, Inc. | MBX | Health Care | 0.27% | $32.36M |
| Cg Oncology, Inc. | CGON | Health Care | 0.26% | $31.12M |
| Newamsterdam Pharma Co. NV | NAMS | Health Care | 0.26% | $30.92M |
| Waters Corp. | WAT | Health Care | 0.26% | $30.71M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Health Care | 0.25% | $30.42M |
| Madrigal Pharmaceuticals, Inc. | MDGL | Health Care | 0.25% | $30.26M |
| Liquidia Corp. | LQDA | Health Care | 0.24% | $29.10M |
| Mirum Pharmaceuticals, Inc. | MIRM | Health Care | 0.24% | $28.98M |
| Beam Therapeutics, Inc. | BEAM | Health Care | 0.24% | $28.90M |
| Nurix Therapeutics, Inc. | NRIX | Health Care | 0.24% | $28.78M |
| West Pharmaceutical Services, Inc. | WST | Health Care | 0.23% | $27.72M |
| Ideaya Biosciences, Inc. | IDYA | Health Care | 0.23% | $27.09M |
| Bridgebio Pharma, Inc. | BBIO | Health Care | 0.23% | $27.05M |
| Teva Pharmaceutical Industries Ltd. | TEVA | Health Care | 0.23% | $26.92M |
| Rhythm Pharmaceuticals, Inc. | RYTM | Health Care | 0.22% | $26.83M |
| Viridian Therapeutics, Inc. | VRDN | Health Care | 0.22% | $26.60M |
| Alkermes PLC | ALKS | Health Care | 0.22% | $26.40M |
| Treeline Bio Ser A-1 Cvt Pfd Stock Pp | — | Health Care | 0.21% | $25.47M |
| Alignment Healthcare, Inc. | ALHC | Health Care | 0.21% | $25.38M |
| Generate Biomedicines Inc lockup | — | Health Care | 0.21% | $24.84M |
| Vaxcyte, Inc. | PCVX | Health Care | 0.21% | $24.75M |
| Rapport Therapeutics, Inc. | RAPP | Health Care | 0.20% | $23.83M |
| Aktis Oncology, Inc. IPO | — | Health Care | 0.20% | $23.36M |
| Immunome, Inc. | IMNM | Health Care | 0.19% | $23.16M |
| Structure Therapeutics, Inc. | GPCR | Health Care | 0.19% | $22.51M |
| Palvella Therapeutics, Inc. | PVLA | Health Care | 0.18% | $22.04M |
| Treeline Bio Ser A Cvt Pfd Stock Pp | — | Health Care | 0.18% | $21.99M |
| Climb Bio, Inc. | CLYM | Health Care | 0.18% | $21.33M |
| Icon PLC | ICLR | Health Care | 0.17% | $20.88M |
| Immunocore Holdings PLC | IMCR | Health Care | 0.17% | $20.49M |
| Kailera Therapeutics, Inc. | KLRA | Health Care | 0.17% | $19.92M |
| Celldex Therapeutics, Inc. | CLDX | Health Care | 0.15% | $18.41M |
THISX Sector Allocation
T. Rowe Price Health Sciences Fund, Inc. holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 98.9% | 240 |
| Funds & ETFs | 0.7% | 4 |
| Corporate Bonds | 0.1% | 1 |
| Consumer Staples | 0.0% | 1 |
| Information Technology | 0.0% | 1 |
| Unknown | 0.3% | 32 |
THISX Country Allocation
Where T. Rowe Price Health Sciences Fund, Inc.'s holdings are domiciled, by percentage of net assets (largest 15).
| Country | % of net assets |
|---|---|
| United States | 92.6% |
| United Kingdom | 1.7% |
| Netherlands | 1.0% |
| Ireland | 0.8% |
| Bermuda | 0.7% |
| Denmark | 0.7% |
| Canada | 0.6% |
| Switzerland | 0.5% |
| Cayman Islands | 0.5% |
| Japan | 0.5% |
| France | 0.2% |
| Israel | 0.2% |
| British Virgin Islands | 0.1% |
| Germany | 0.1% |
| Singapore | 0.1% |
THISX Portfolio Allocation
Asset-class allocation of T. Rowe Price Health Sciences Fund, Inc. by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.4% |
| Cash & Equivalents | 0.6% |
| Fixed Income | 0.1% |
THISX Debt Constituents
Largest debt holdings of T. Rowe Price Health Sciences Fund, Inc. by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Immunocore Holdings Cb 2.50% 2/30 | 0.11% |
| Delfi Diagnostics CVT Prom Note PP | 0.01% |
| Kartos Therapeutics CVT Prom Note 03/27 PP | 0.01% |
| Reflexion Med CVT Note issued 072525 PP | 0.01% |
| Reflexion Med CVT Note issued 081325 PP | 0.01% |
| Reflexion Med CVT Note issued 082725 PP | 0.01% |
| Kartos Therapeutics CVT Note 05/27 PP | 0.00% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.